MedPath

ature and mechanism of cognitive deficits following chemotherapy: an (f)MRI study

Conditions
cognitive deficits
memory and concentration problems
10009841
Registration Number
NL-OMON31092
Lead Sponsor
Antoni van Leeuwenhoek Ziekenhuis
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
40
Inclusion Criteria

all groups:
-female
-sufficient proficiency in the Dutch language;cross-sectional part:
-participation in previous neuropsychological study
-having been treated with high-dose chemotherapy (CTC);prospective part, experimental group
-newly diagnosed breast cancer patients without distant metastases that will receive chemotherapy (ACdd + T);prospective part, control group
-newly diagnosed breast cancer patients without distant metastases that will not receive chemotherapy

Exclusion Criteria

-relapse and/or metastases
-excessive use of alcohol or drugs
-use of psychotropic medication
-neurologic or psychiatric disorders that may influence cognitive functioning
-conditions that preclude MRI examination

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath